In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia

Blood

Volumn 89, Issue 8, 1997, Pages 2959-2965

  Hongo, Teruaki ^a   Yajima, Shuhei ^b   Sakurai, Minoru ^b   Horikoshi, Yasuo ^b   Hanada, Ryoji ^b  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACLARUBICIN; ANTINEOPLASTIC AGENT; ASPARAGINASE; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; MELPHALAN; METHOTREXATE; MITOMYCIN C; MITOXANTRONE; PIRARUBICIN; PREDNISOLONE; VINBLASTINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AGE; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; DOSE RESPONSE; DRUG SENSITIVITY; HUMAN; INFANT; LETHAL DOSE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RELAPSE;

EID: 0030984290     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.8.2959     Document Type: Article

References (21)

1. Pui CH, Crist WM: Biology and treatment of acute lymphoblastic leukemia. J Pediatr 124:491, 1994
2. Pui CH: Childhood leukemias. N Engl J Med 332:1618, 1995
3. Wiersma SR, Ortega J, Sobel E, Weinberg KI: Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. N Engl J Med 324:800, 1991
4. Bosanquet AG: Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assay. Lancet 337:711, 1991
5. Bird MG, Bosanquet AG, Forskitt S, Gilby ED: Long-term comparison of results of a drug sensitivity assay in vitro with patients response in lymphatic neoplasms. Cancer 61:1104, 1988
6. Pieters R, Huismans DR, Loonen AH, Hählen K, van der Does-van den Berg A, van Wering ER, Veerman ALP: Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia. Lancet 338:399, 1991
7. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, J Immunol Methods 65:55, 1983
8. Twentyman PR, Luscombe M: A study of some variables in a tetrazolium dye (MTT) based assays for cell growth and chemosensitivity. Br J Cancer 56:279, 1987
9. Campling BG, Pym J, Galbraith PR, Cole SPC: Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells. Leuk Res 12:823, 1988
10. Santini V, Bernabei PA, Vestro LS, Pozzo OD, Bezzini R, Viano I, Gattei V, Saccardi R, Ferrini PR: In vitro chemosensitivity testing of leukemic cells: Prediction of response to chemotherapy in patients with acute non-lymphocytic leukemia. Hematol Oncol 7:287, 1989
11. Sargent JM, Taylor CG: Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia. Br J Cancer 60:206, 1989
12. Hongo T, Fujii Y, Igarashi Y: An in vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia. Cancer 65:1263, 1990
13. Hongo T, Fujii Y: In vitro chemosensitivity of lymphoblasts at relapse in childhood leukemia using the MTT assay. Int J Hematol 54:219, 1991
14. Pieters R, Loonen AH, Huismans DR, Broekema GJ, Dirven MWJ, Heyenbrok MW, Hählen K, Veerman ALP: In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. Blood 76:2327, 1990
15. Kaspers GJL, Smets LA, Pieters R, van Zantwijk CH, van Wering ER, Veerman ALP: Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: Results of an in vitro study. Blood 85:751, 1995
16. Pieters R, Kaspers GJL, van Wering ER, Huismans DR, Loonen AH, Hählen K, Veerman ALP: Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia. Leukemia 7:392, 1993
17. Kaspers GJL, Kardos G, Pieters R, van Zantwijk CH, Klumper E, Hählen K, De Waal FC, van Wering ER, Veerman ALP: Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: A preliminary report. Leukemia 8:1224, 1994
18. Klumper E, Pieters R, Veerman AJP, Huismans DR, Loonen AH, Hählen K, Kaspers GJL, van Wering ER, Hartmann R, Henze G: In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. Blood 86:3861, 1995
19. Pieters R, Huismans DR, Loonen AH, Peters GJ, Hählen K, van der Does-van den Berg A, van Wering ER, Veerman ALP: Relation of 5′-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia. Leuk Res 16:873, 1992
20. Pieters R, Huismans DR, Loonen AH, Peters GJ, Hählen K, van der Does-van den Berg A, van Wering ER, Veerman ALP: Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: Relation with differentiation stage, in vitro drug resistance and clinical prognosis. Leukemia 6:375, 1992
21. Klumper E, Giaccone G, Pieters R, Broekema G, van Ark-Otte J, van Wering ER, Kaspers GJL, Veerman ALP: Topoisomerase II alpha gene expression in childhood acute lymphoblastic leukemia. Leukemia 9:1653, 1995